Trials / Completed
CompletedNCT03654573
The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- CorFlow Therapeutics AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
First-in-Human study to assess the CoFI™ device related safety and the feasibility of the diagnostic and the therapeutic sequence as well as the correlation between the dynamic microvascular resistance (dMVR) and microvascular obstruction (MVO) as measured by MRI in patients presenting with acute ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CorFlow Controlled Flow Infusion System - CoFI™ | The CorFlow CoFI™ System is intended to assess the dynamic microvascular resistance and to treat microvascular obstruction in the coronary vasculature of patients following PCI with stent placement. |
Timeline
- Start date
- 2019-06-04
- Primary completion
- 2024-12-18
- Completion
- 2024-12-18
- First posted
- 2018-08-31
- Last updated
- 2025-03-19
Locations
8 sites across 3 countries: Lithuania, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT03654573. Inclusion in this directory is not an endorsement.